4 Months on Mounjaro: What Most People Notice at This Stage

What dose are most people on after four months?

Mounjaro treatment starts at 2.5 mg, a tolerability dose whose main job is letting your body adjust, not producing large-scale weight loss. After roughly four weeks, most people step up to 5 mg, then 7.5 mg, and so on in four-week increments, guided by how well each level is tolerated. Four months in, that puts most people somewhere between 7.5 mg and 12.5 mg, depending on when they started and whether any dose steps were paused because of side effects.

That range matters because the evidence from SURMOUNT-1, published in the New England Journal of Medicine, shows a clear dose-response relationship: higher doses produce greater average weight loss. Reaching 10 mg or above tends to be where the most substantial change is felt. So if you are at four months and still on a lower dose because titration has been slow, that is not a sign of failure, it is your prescriber managing your safety and comfort correctly.

Prescribers at our clinical team review each dose increase individually rather than applying a fixed schedule. If you have questions about whether your current dose is right for you, that conversation belongs with your prescriber, not a forum.

Is the weight loss at month four what the trials predict?

This is a question worth being honest about, because the trial figures can create unrealistic expectations. SURMOUNT-1 reported average body-weight reductions of around 20–21% at 15 mg over 72 weeks, roughly a year and a half. Four months is about 17 weeks. Proportionally, a significant share of that loss does tend to occur in the first half of treatment as doses increase and appetite suppression deepens, but individual variation is wide.

Some people see a steep drop in months one to three, then a temporary plateau around months three to five as the body adjusts. Others lose more steadily throughout. Neither pattern is wrong. If you are curious about what people typically report at a slightly earlier or later stage, the three-month experience and the six-month picture both illustrate how the trajectory evolves.

If you feel your results are lagging significantly behind what you expected, that is a real and valid feeling, and it is worth raising with your prescriber rather than assuming something is wrong. Occasionally there are factors worth reviewing: protein intake, sleep quality, activity level, or whether a dose adjustment is appropriate. The NHS tirzepatide page also gives a grounded overview of what the medicine does and does not do.

Side effects at month four: calmer than the start, but not always gone

For most people, the roughest side-effect period is behind them by month four. Nausea, loose stools, fatigue and indigestion are most common in the first few weeks of treatment and after each dose step up. By month four, many people find their current dose feels largely settled, the side effects that troubled them at 2.5 mg or 5 mg are no longer present at their current higher dose, simply because the body has had time to adapt.

That said, if a dose increase happened recently, a fresh wave of mild GI symptoms is normal and usually brief. The pattern tends to repeat at each step: a week or two of adjustment, then things calm down. There is a detailed look at the full side-effect picture on the tirzepatide information page, which is worth reading if you are still finding certain doses difficult.

One thing our prescribers hear regularly at this stage: people who felt quite unwell in month one are often surprised by how much more comfortable month four feels. The adjustment is real, and it does pass for the majority. If side effects remain severe or you experience sudden, intense abdominal pain (particularly pain that spreads to the back) seek medical attention promptly rather than waiting for your next review.

What decisions does month four typically bring?

Month four is often a decision point. You may be wondering whether to continue to the maximum licensed dose (15 mg), whether to stay at your current dose if it is working well, or how long treatment should run. These are exactly the questions a prescriber should be helping you navigate rather than leaving you to work out alone.

For context on costs as treatment continues, the Mounjaro cost page explains how UK private pricing works and what an all-in price should include. It is worth understanding, because the cost picture over six or twelve months is different from the first month's spend.

If you started elsewhere and are thinking about continuing through a regulated UK pharmacy, the Mounjaro page sets out how the process works at a GPhC-registered pharmacy with proper clinical oversight. Transfer patients are always welcome at nume, and a prescriber reviews each case before any repeat is issued, there are no automatic refills.

Thinking about what comes after four months? The two-month retrospective can be a useful reference point for seeing how far you have come, and our FAQs cover many of the common questions that come up mid-treatment. When you are ready to speak to someone clinically, you can speak to our prescribers through a free consultation, the same day, reviewed by a real clinician.